Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease

Medicine & Life Sciences

• Enbucrilate 100%
• quinoline 95%
• Cyanoacrylates 83%
• Nanoparticles 59%
• Alzheimer Disease 52%
• Brain 32%
• Amyloid 19%
• peptide A42 15%
• Amyloid Plaques 14%
• 8-chloro-7-hydroxyquinoline 14%
• Radio 13%
• Blood-Brain Barrier 13%
• Brain Diseases 12%
• N-(8-aminohexyl)-5-iodonaphthalene-1-sulfonamide 11%
• Clioquinol 11%
• peptide A 10%
• Photons 7%
• Single-Photon Emission-Computed Tomography 6%
• Biomedical Research 6%
• Paraffin 6%
• Transgenic Mice 6%
• Neurodegenerative Diseases 5%
• Metals 5%
• Dementia 5%
• Ions 5%
• Early Diagnosis 5%
• Tomography 4%
• Elderly 4%
• Biomarkers 4%
• Staining and Labeling 4%
• Equipment and Supplies 4%
• In Vitro Techniques 2%
• Pharmaceutical Preparations 2%

Engineering & Materials Science

• Nanoparticles 65%
• Amyloid 56%
• Brain 55%
• Blood-Brain Barrier 23%
• Imaging techniques 20%
• Phosphors 17%
• Peptides 17%
• Metal ions 9%
• Photons 7%
• Paraffins 7%
• Tomography 6%
• Tissue 5%

Chemical Compounds

• Nanoparticle 33%
• Photon Emission 9%
• Peptide 7%
• Clearance 7%
• Biological Marker 6%
• Disorder 5%
• Dose 5%
• Metal Ion 4%
• Probe 4%
• Drug 3%